PTGER4阳性巨噬细胞促进炎症后肠上皮屏障再生
该研究探讨前列腺素E2受体PTGER4在肠道巨噬细胞分化及黏膜愈合中的作用。在IBD患者和DSS结肠炎小鼠中发现表达PTGER4的巨噬细胞具有黏膜愈合特性;Csf1r-iCre Ptger4fl/fl小鼠黏膜愈合和上皮屏障再生受损。机制上PGE2经MAPK促进单核来源PTGER4+巨噬细胞分泌CXCL1,驱动再生隐窝上皮细胞分化增殖。
要点
- PTGER4+肠道巨噬细胞在人和小鼠中均具有黏膜愈合特性
- 髓系Ptger4缺失小鼠在DSS结肠炎中黏膜愈合和上皮屏障再生受损
- PGE2经MAPK促PTGER4+巨噬细胞分泌CXCL1驱动上皮再生
核心结论
- PTGER4+肠道巨噬细胞对支持肠道干细胞龛和损伤上皮再生至关重要。
- 该结果为开发促进巨噬细胞愈合功能、促进IBD缓解的新型治疗靶点奠定基础。
研究设计与样本
- 研究在IBD患者和肠道炎症小鼠模型中探讨PGE2受体PTGER4对肠道巨噬细胞分化的作用。
- 在DSS诱导结肠炎中研究Csf1r-iCre Ptger4fl/fl小鼠的黏膜愈合与肠上皮屏障再生。
- 用上皮类器官分化研究PTGER4+巨噬细胞分泌分子的效应。
主要发现
- 在人和小鼠中描述了一群具有黏膜愈合特性的表达PTGER4的肠道巨噬细胞。
- Csf1r-iCre Ptger4fl/fl小鼠在DSS结肠炎模型中显示黏膜愈合和上皮屏障再生缺陷。
- 黏膜PGE2水平升高经MAPK触发单核来源PTGER4+巨噬细胞分泌CXCL1。
- CXCL1在结肠炎期间驱动再生隐窝的上皮细胞分化与增殖。
- 用载有MAPK激动剂的脂质体靶向巨噬细胞可增强条件性巨噬细胞PTGER4缺陷小鼠体内CXCL1产生,恢复其上皮再生并促进黏膜愈合。
临床怎么用
- 可考虑将促进PTGER4+巨噬细胞CXCL1分泌的MAPK通路作为促进IBD黏膜愈合的潜在治疗方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Dysfunctional resolution of intestinal inflammation and altered mucosal healing are essential features in the pathogenesis of inflammatory bowel disease (IBD). Intestinal macrophages are vital in the process of inflammation resolution, but the mechanisms underlying their mucosal healing capacity remain elusive. DESIGN: We investigated the role of the prostaglandin E2 (PGE2) receptor PTGER4 on the differentiation of intestinal macrophages in patients with IBD and mouse models of intestinal inflammation. We studied mucosal healing and intestinal epithelial barrier regeneration in Csf1r-iCre Ptger4fl/fl mice during dextran sulfate sodium (DSS)-induced colitis. The effect of PTGER4+ macrophage secreted molecules was investigated on epithelial organoid differentiation. RESULTS: Here, we describe a subset of PTGER4-expressing intestinal macrophages with mucosal healing properties both in humans and mice. Csf1r-iCre Ptger4fl/fl mice showed defective mucosal healing and epithelial barrier regeneration in a model of DSS colitis. Mechanistically, an increased mucosal level of PGE2 triggers chemokine (C-X-C motif) ligand 1 (CXCL1) secretion in monocyte-derived PTGER4+ macrophages via mitogen-activated protein kinases (MAPKs). CXCL1 drives epithelial cell differentiation and proliferation from regenerating crypts during colitis. Specific therapeutic targeting of macrophages with liposomes loaded with an MAPK agonist augmented the production of CXCL1 in vivo in conditional macrophage PTGER4-deficient mice, restoring their defective epithelial regeneration and favouring mucosal healing. CONCLUSION: PTGER4+ intestinal macrophages are essential for supporting the intestinal stem cell niche and regeneration of the injured epithelium. Our results pave the way for the development of a new class of therapeutic targets to promote macrophage healing functions and favour remission in patients with IBD.
引用
- Na YR, Jung D, Stakenborg M, et al. Prostaglandin E2 receptor PTGER4-expressing macrophages promote intestinal epithelial barrier regeneration upon inflammation. Gut. 2021. PMID: 33558271. doi:10.1136/gutjnl-2020-322146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。